The Insurance Authority ("IA") and Hong Kong Monetary Authority ("HKMA") issued a circular on 13 March 2025 providing clarity on the regulatory framework for Indexed Universal Life ("IUL") insurance products in Hong Kong.
IUL is emerging as a key offering in the high net worth segment, complementing existing Universal Life and Participating Life products. As insurers prepare to enter this market, they must consider factors such as time-to-market, sales compliance, accounting, derivatives operations, modelling capabilities, and risk governance.
This publication explores the key implementation considerations for Hong Kong insurers launching IUL products and provides insights on building the necessary capabilities to maintain competitiveness in this growing market segment.
